BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 11157745)

  • 1. Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein.
    Wong C; Xiong LW; Horiuchi M; Raymond L; Wehrly K; Chesebro B; Caughey B
    EMBO J; 2001 Feb; 20(3):377-86. PubMed ID: 11157745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state.
    Horiuchi M; Caughey B
    EMBO J; 1999 Jun; 18(12):3193-203. PubMed ID: 10369660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of protease-resistant prion protein inhibitors in cell cultures infected with two strains of mouse and sheep scrapie.
    Kocisko DA; Engel AL; Harbuck K; Arnold KM; Olsen EA; Raymond LD; Vilette D; Caughey B
    Neurosci Lett; 2005 Nov; 388(2):106-11. PubMed ID: 16039063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
    Sasaki K; Minaki H; Iwaki T
    J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between heterologous forms of prion protein: binding, inhibition of conversion, and species barriers.
    Horiuchi M; Priola SA; Chabry J; Caughey B
    Proc Natl Acad Sci U S A; 2000 May; 97(11):5836-41. PubMed ID: 10811921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-free formation of protease-resistant prion protein.
    Kocisko DA; Come JH; Priola SA; Chesebro B; Raymond GJ; Lansbury PT; Caughey B
    Nature; 1994 Aug; 370(6489):471-4. PubMed ID: 7913989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening a library of potential prion therapeutics against cellular prion proteins and insights into their mode of biological activities by surface plasmon resonance.
    Touil F; Pratt S; Mutter R; Chen B
    J Pharm Biomed Anal; 2006 Mar; 40(4):822-32. PubMed ID: 16242887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of rafts in the fibrillization and aggregation of prions.
    Pinheiro TJ
    Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semiautomated cell-free conversion of prion protein: applications for high-throughput screening of potential antiprion drugs.
    Breydo L; Bocharova OV; Baskakov IV
    Anal Biochem; 2005 Apr; 339(1):165-73. PubMed ID: 15766724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication.
    Nunziante M; Kehler C; Maas E; Kassack MU; Groschup M; Schätzl HM
    J Cell Sci; 2005 Nov; 118(Pt 21):4959-73. PubMed ID: 16219680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Truncated PrP(c) in mammalian brain: interspecies variation and location in membrane rafts.
    Laffont-Proust I; Hässig R; Haïk S; Simon S; Grassi J; Fonta C; Faucheux BA; Moya KL
    Biol Chem; 2006 Mar; 387(3):297-300. PubMed ID: 16542151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient conversion of normal prion protein (PrP) by abnormal hamster PrP is determined by homology at amino acid residue 155.
    Priola SA; Chabry J; Chan K
    J Virol; 2001 May; 75(10):4673-80. PubMed ID: 11312338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of altered aspartyl residues in the scrapie associated form of prion protein.
    Weber DJ; McFadden PN; Caughey B
    Biochem Biophys Res Commun; 1998 May; 246(3):606-8. PubMed ID: 9618258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro amplification of protease-resistant prion protein requires free sulfhydryl groups.
    Lucassen R; Nishina K; Supattapone S
    Biochemistry; 2003 Apr; 42(14):4127-35. PubMed ID: 12680767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The state of the prion.
    Weissmann C
    Nat Rev Microbiol; 2004 Nov; 2(11):861-71. PubMed ID: 15494743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing misfolding of the prion protein by trimethylamine N-oxide.
    Bennion BJ; DeMarco ML; Daggett V
    Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycosylation influences cross-species formation of protease-resistant prion protein.
    Priola SA; Lawson VA
    EMBO J; 2001 Dec; 20(23):6692-9. PubMed ID: 11726505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells.
    Caughey B; Raymond GJ
    J Virol; 1993 Feb; 67(2):643-50. PubMed ID: 7678300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered prion protein glycosylation in the aging mouse brain.
    Goh AX; Li C; Sy MS; Wong BS
    J Neurochem; 2007 Feb; 100(3):841-54. PubMed ID: 17144900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PrP(Sc) of scrapie 263K propagates efficiently in spleen and muscle tissues with protein misfolding cyclic amplification.
    Shi S; Dong CF; Wang GR; Wang X; An R; Chen JM; Shan B; Zhang BY; Xu K; Shi Q; Tian C; Gao C; Han J; Dong XP
    Virus Res; 2009 Apr; 141(1):26-33. PubMed ID: 19162101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.